by Thomas Currie | Jun 1, 2022 | Blog
Unculturable soil bacteria is a misleading term, as these bacteria hypothetically can be cultured. More accurately, ‘unculturable’ bacteria cannot be cultured using traditional techniques, such as traditional agars. These unknown bacteria are a potential untouched pool of medically useful secondary metabolites, such as antibiotics.
by Sally Cox | May 10, 2022 | Blog, MHRA
There is a new MHRA Green Guide Update 2022 updated edition of the Rules and Guidance for Pharmaceutical Distributors called the MHRA Green Guide.
by Steven Hewison | May 6, 2022 | Blog, MHRA
Compliance Monitoring Process – from April this year the MHRA are piloting a different approach to the monitoring of companies that are referred to the MHRA’s IAG (Inspection Action Group) for failure to comply with the standards of Good Manufacturing Practice or Good Distribution Practice.
by Thomas Currie | May 6, 2022 | Blog, Covid 19
Drug repurposing offers the possibility of a huge untapped source of safe and effective therapies for both common and rare conditions.
by Sehar Shahid | May 6, 2022 | Blog, NHS
t National Patient Safety Team, and the British Association of Dermatologists, on the risk of inadvertent oral administration of potassium permanganate and the fear over safety when used.
by Sally Cox | Apr 19, 2022 | Audit, Blog, Training
The role of the auditor is not only to confirm compliance but is key to the improvement of processes across the company. Whether you work to GDP or ISO standards, it is a requirement that audits are carried out either internally or at the premises of your key suppliers to confirm compliance.
by Sally Cox | Apr 19, 2022 | Blog, Export Training, Training
The pharmaceutical industry is a highly regulated sector where the paramount focus on minimising the risk to patient safety has led to significant changes in recent years.
by Sally Cox | Mar 31, 2022 | Blog, NHS
As early as next year pharmacogenomic tests could be made available on the NHS.
by Sally Cox | Mar 31, 2022 | Blog, MHRA, NHS
Mobocertinib has now been fast-tracked and will be made available to NHS England eligible lung cancer patients within weeks.
by Sally Cox | Mar 25, 2022 | Blog, Cogent Gold Standard, Training
As Pharmacy Consulting is now once again able to offer our popular ‘Face to Face’ Cogent Gold Standard Responsible Person Training Course’.